Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program)
Olga V. Leontieva(Roswell Park Comprehensive Cancer Center), Mikhail V. Blagosklonny(Roswell Park Comprehensive Cancer Center)
Cited by 65
Related Papers
The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway
|Aging|2010|274
Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program
|Proceedings of the National Academy of Sciences|2014|153
Identification of Two Distinct Pathways of Protein Kinase Cα Down-regulation in Intestinal Epithelial Cells
|Journal of Biological Chemistry|2004|104
Suppression of replicative senescence by rapamycin in rodent embryonic cells
|Cell Cycle|2012|83
Prevention of Age-Related Macular Degeneration–Like Retinopathy by Rapamycin in Rats
|American Journal Of Pathology|2012|81